Mackenzie Financial Corp Sarepta Therapeutics, Inc. Transaction History

Mackenzie Financial Corp

$66.8 Billion
Q3 2024

A detailed history of Mackenzie Financial Corp transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 32,500 shares of SRPT stock, worth $3.87 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

32,500

Previous 61,261 46.95%

Holding current value

$3.87 Million

Previous $9.68 Million 58.06%

% of portfolio

0.01%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$124.33 - $156.75 $3.58 Million - $4.51 Million	-28,761 Reduced 46.95%	32,500 $4.06 Million
Q2 2024 Aug 14, 2024	BUY	$113.33 - $163.85 $2.81 Million - $4.07 Million	24,836 Added 68.18%	61,261 $9.68 Million
Q1 2024 May 10, 2024	BUY	$93.7 - $141.53 $2.46 Million - $3.71 Million	26,216 Added 256.79%	36,425 $4.72 Million
Q4 2023 Jan 30, 2024	SELL	$67.31 - $124.76 $693,831 - $1.29 Million	-10,308 Reduced 50.24%	10,209 $984,000
Q3 2023 Oct 25, 2023	SELL	$102.5 - $123.59 $1.26 Million - $1.52 Million	-12,330 Reduced 37.54%	20,517 $2.49 Million
Q2 2023 Aug 03, 2023	SELL	$106.4 - $157.19 $844,284 - $1.25 Million	-7,935 Reduced 19.46%	32,847 $3.76 Million
Q1 2023 Apr 24, 2023	SELL	$117.53 - $155.99 $493,038 - $654,378	-4,195 Reduced 9.33%	40,782 $5.62 Million
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $386,394 - $506,190	3,831 Added 9.31%	44,977 $5.83 Million
Q3 2022 Oct 07, 2022	BUY	$75.71 - $119.24 $2.83 Million - $4.46 Million	37,393 Added 996.35%	41,146 $4.55 Million
Q2 2022 Aug 10, 2022	BUY	$62.69 - $88.44 $235,275 - $331,915	3,753 New	3,753 $281,000
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $488,048 - $1.14 Million	-6,755 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$125.56 - $178.74 $376,177 - $535,505	-2,996 Reduced 30.73%	6,755 $1.15 Million
Q3 2020 Nov 13, 2020	SELL	$127.12 - $172.34 $637,888 - $864,802	-5,018 Reduced 33.98%	9,751 $1.37 Million
Q2 2020 Aug 13, 2020	BUY	$93.0 - $171.7 $1.37 Million - $2.54 Million	14,769 New	14,769 $2.37 Million
Q2 2019 Aug 14, 2019	SELL	$112.21 - $151.95 $270,650 - $366,503	-2,412 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$106.67 - $151.68 $181,659 - $258,311	-1,703 Reduced 41.39%	2,412 $287,000
Q4 2018 Feb 06, 2019	BUY	$97.32 - $148.76 $54,499 - $83,305	560 Added 15.75%	4,115 $449,000
Q3 2018 Nov 15, 2018	BUY	$115.31 - $161.51 $409,927 - $574,168	3,555 New	3,555 $574,000

Others Institutions Holding SRPT

# of Institutions

529

Shares Held

84.2M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Account

Mackenzie Financial Corp Sarepta Therapeutics, Inc. Transaction History